101 related articles for article (PubMed ID: 9300690)
1. Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain.
Liu D; Sy MS
J Immunol; 1997 Sep; 159(6):2702-11. PubMed ID: 9300690
[TBL] [Abstract][Full Text] [Related]
2. Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid.
Liu D; Liu T; Sy MS
Cell Immunol; 1998 Dec; 190(2):132-40. PubMed ID: 9878114
[TBL] [Abstract][Full Text] [Related]
3. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.
Liu D; Zhang D; Mori H; Sy MS
Cell Immunol; 1996 Nov; 174(1):73-83. PubMed ID: 8929456
[TBL] [Abstract][Full Text] [Related]
4. The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding.
Lesley J; English N; Charles C; Hyman R
Eur J Immunol; 2000 Jan; 30(1):245-53. PubMed ID: 10602047
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
[TBL] [Abstract][Full Text] [Related]
6. Role of CD44 cytoplasmic domain in hyaluronan binding.
Perschl A; Lesley J; English N; Trowbridge I; Hyman R
Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CD44-hyaluronan interactions in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid B cells by PMA and interleukin-4.
Kryworuchko M; Gee K; Diaz-Mitoma F; Kumar A
Cell Immunol; 1999 May; 194(1):54-66. PubMed ID: 10357881
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma inhibits CD44-hyaluronan interactions in normal human B lymphocytes.
Kryworuchko M; Diaz-Mitoma F; Kumar A
Exp Cell Res; 1999 Jul; 250(1):241-52. PubMed ID: 10388538
[TBL] [Abstract][Full Text] [Related]
9. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions.
Bajorath J
Proteins; 2000 May; 39(2):103-11. PubMed ID: 10737932
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes.
Bourguignon LY; Gilad E; Peyrollier K; Brightman A; Swanson RA
J Neurochem; 2007 May; 101(4):1002-17. PubMed ID: 17403031
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli.
Banerji S; Day AJ; Kahmann JD; Jackson DG
Protein Expr Purif; 1998 Dec; 14(3):371-81. PubMed ID: 9882571
[TBL] [Abstract][Full Text] [Related]
13. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration.
Singleton PA; Bourguignon LY
Cell Motil Cytoskeleton; 2002 Dec; 53(4):293-316. PubMed ID: 12378540
[TBL] [Abstract][Full Text] [Related]
14. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
15. Requirements for signal delivery through CD44: analysis using CD44-Fas chimeric proteins.
Ishiwatari-Hayasaka H; Fujimoto T; Osawa T; Hirama T; Toyama-Sorimachi N; Miyasaka M
J Immunol; 1999 Aug; 163(3):1258-64. PubMed ID: 10415022
[TBL] [Abstract][Full Text] [Related]
16. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R
J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376
[TBL] [Abstract][Full Text] [Related]
17. PKC-induced stiffening of hyaluronan/CD44 linkage; local force measurements on glioma cells.
Lamontagne CA; Grandbois M
Exp Cell Res; 2008 Jan; 314(2):227-36. PubMed ID: 17698062
[TBL] [Abstract][Full Text] [Related]
18. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
Wallach SB; Friedmann A; Naor D
Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases.
Gee K; Kryworuchko M; Kumar A
Arch Immunol Ther Exp (Warsz); 2004; 52(1):13-26. PubMed ID: 15053229
[TBL] [Abstract][Full Text] [Related]
20. Group A Streptococcus tissue invasion by CD44-mediated cell signalling.
Cywes C; Wessels MR
Nature; 2001 Dec; 414(6864):648-52. PubMed ID: 11740562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
